Heart disease is the leading cause of death for women, yet it remains underrepresented in discussions about women’s health. Too often, the focus centers on fertility, maternal health, or menopause, while the risks of cardiovascular disease are overlooked. 

For decades, medical research primarily included men, leaving gaps in our understanding of how heart disease manifests in women. Hormonal changes, pregnancy complications, and unique physiological factors can all play significant roles in heart health and how drug efficacy might differ for women, yet they remain underexplored. Even as clinical trial inclusion improves, progress is slow and much remains unknown. 

Technology is starting to bridge these gaps. Tools like AI and wearable devices, like Oura Ring and smart watches, are advancing our ability to track and monitor women’s heart health, offering personalized insights that reflect women’s unique needs. Increased investment in these innovations is critical to improving outcomes and addressing disparities in care. 

This February, American Heart Month provides an opportunity to amplify awareness of women’s cardiovascular health. By making sure protocols prioritize enrolling more women in cardiovascular disease clinical trials and research, leveraging technology, and fostering conversations, we can equip women with the tools they need to protect their hearts—and their futures.